Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials - PubMed (original) (raw)
Meta-Analysis
. 2015 Jul-Aug;31(7-8):923-30.
doi: 10.1016/j.nut.2014.11.018. Epub 2014 Dec 24.
Affiliations
- PMID: 26059365
- DOI: 10.1016/j.nut.2014.11.018
Meta-Analysis
Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials
Ken Sato et al. Nutrition. 2015 Jul-Aug.
Abstract
Objectives: Vitamin E is often used in the treatment of nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatitis (NASH); however, the magnitude of treatment response associated with vitamin E in improving liver function and histology in NAFLD/NASH has not, to our knowledge, been quantified systematically. Thus, we conducted a meta-analysis of randomized controlled trials (RCTs) using vitamin E in the treatment of NAFLD/NASH.
Methods: PubMed, Medline, and Cochrane Library Full Text Database, and Japan Medical-Literature Database (Igaku Chuo Zasshi) were searched until March 2014, and five RCTs were identified for meta-analysis.
Results: According to a random effect model analysis of the five studies, vitamin E significantly reduced aspartate transaminase (AST) by -19.43 U/L, alanine aminotransferase (ALT) by -28.91 U/L, alkaline phosphatase (ALP) by -10.39 U/L, steatosis by -0.54 U/L, inflammation by -0.20 U/L, and hepatocellular ballooning by -0.34 U/L compared with the control group. Vitamin E treatment with NASH adult patients showed obvious reductions in not only AST of -13.91 U/L, ALT by -22.44 U/L, steatosis of -0.67 U/L, inflammation of -0.20 U/L, but also fibrosis of -0.30 U/L compared to the control treatment.
Conclusions: Vitamin E significantly improved liver function and histologic changes in patients with NAFLD/NASH.
Keywords: Meta-analysis; NAFLD; NASH; Nonalcoholic steatohepatitis; Vitamin E; α-Tocopherol.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
- Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta-analysis.
Ji HF, Sun Y, Shen L. Ji HF, et al. Nutrition. 2014 Sep;30(9):986-91. doi: 10.1016/j.nut.2014.01.016. Epub 2014 Feb 20. Nutrition. 2014. PMID: 24976430 - Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology.
Corey KE, Misdraji J, Gelrud L, King LY, Zheng H, Malhotra A, Chung RT. Corey KE, et al. Dig Dis Sci. 2015 Aug;60(8):2523-8. doi: 10.1007/s10620-015-3650-8. Epub 2015 Apr 4. Dig Dis Sci. 2015. PMID: 25840922 Free PMC article. - Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.
Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, Abrams SH, Scheimann AO, Sanyal AJ, Chalasani N, Tonascia J, Ünalp A, Clark JM, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR; Nonalcoholic Steatohepatitis Clinical Research Network. Lavine JE, et al. JAMA. 2011 Apr 27;305(16):1659-68. doi: 10.1001/jama.2011.520. JAMA. 2011. PMID: 21521847 Free PMC article. Clinical Trial. - Vitamin E and nonalcoholic fatty liver disease.
Pacana T, Sanyal AJ. Pacana T, et al. Curr Opin Clin Nutr Metab Care. 2012 Nov;15(6):641-8. doi: 10.1097/MCO.0b013e328357f747. Curr Opin Clin Nutr Metab Care. 2012. PMID: 23075940 Free PMC article. Review. - Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.
Angelico F, Burattin M, Alessandri C, Del Ben M, Lirussi F. Angelico F, et al. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD005166. doi: 10.1002/14651858.CD005166.pub2. Cochrane Database Syst Rev. 2007. PMID: 17253544 Review.
Cited by
- Dietary Pattern's Role in Hepatic Epigenetic and Dietary Recommendations for the Prevention of NAFLD.
Martín Barraza JI, Bars-Cortina D. Martín Barraza JI, et al. Nutrients. 2024 Sep 3;16(17):2956. doi: 10.3390/nu16172956. Nutrients. 2024. PMID: 39275272 Free PMC article. Review. - Methotrexate-induced hepatotoxicity in rats and the therapeutic properties of vitamin E: a histopathologic and flowcytometric research.
Akman AU, Erisgin Z, Turedi S, Tekelioglu Y. Akman AU, et al. Clin Exp Hepatol. 2023 Dec;9(4):359-367. doi: 10.5114/ceh.2023.132251. Epub 2023 Oct 27. Clin Exp Hepatol. 2023. PMID: 38774203 Free PMC article. - Exploring the interactions between metabolic dysfunction-associated fatty liver disease and micronutrients: from molecular mechanisms to clinical applications.
Liu Y, Qin X, Chen T, Chen M, Wu L, He B. Liu Y, et al. Front Nutr. 2024 Mar 14;11:1344924. doi: 10.3389/fnut.2024.1344924. eCollection 2024. Front Nutr. 2024. PMID: 38549744 Free PMC article. Review. - Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?
Serbis A, Polyzos SA, Paschou SA, Siomou E, Kiortsis DN. Serbis A, et al. Endocrine. 2024 Sep;85(3):988-1006. doi: 10.1007/s12020-024-03783-7. Epub 2024 Mar 22. Endocrine. 2024. PMID: 38519764 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical